Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment

Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment

Background/Aims Data on treatment efficacy and safety of glecaprevir/pibrentasvir (GLE/PIB) for chronic hepatitis C virus (HCV) infection in Asian patients with severe renal impairment are limited. This study aimed to study the treatment and side effects of GLE/PIB in these patients infected with no...

Full description

Bibliographic Details
Main Authors: Desmond Y. H. Yap, Kevin S. H. Liu, Yu-Chun Hsu, Grace L. H. Wong, Ming-Chang Tsai, Chien-Hung Chen, Ching-Sheng Hsu, Yee Tak Hui, Michael K. K. Li, Chen-Hua Liu, Yee-Man Kan, Ming-Lung Yu, Man-Fung Yuen
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2020-10-01
Series:Clinical and Molecular Hepatology
Subjects:
glecaprevir and pibrentasvir
hepatitis c
renal insufficiency
Online Access:http://e-cmh.org/upload/pdf/cmh-2020-0058.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-2020-0058.pdf

Similar Items